INS and Alzheimer disease: One of the ways used to manipulate aging in vivo is the decrease the insulin IGF-1 signaling, the main insulin pathway known to regulate aging together with PI3K/Akt pathway; these two pathways can control aging and are altered in neurodegenerative disorders, including PD, AD and HD [80].